Purchase and Sale of GE Healthcare Assets

Main article: GE Healthcare

GE Healthcare financials

2023

Buying the company Caption Health

On 9 February 2023, the company GE HealthCare announced that it had signed an agreement to acquire the firm Caption Health, which is developing artificial intelligence ultrasound systems ULTRASONOGRAPHY. here

=Imactis Purchase

On January 9, 2023, GE HealthCare announced the acquisition of Imactis, a developer of interventional tomography guidance technology. The companies declined to publicly disclose the financial terms of the deal. Read more here.

2021

Purchase of the manufacturer of ultrasound systems for surgical operations BK Medical for $1.45 billion

On September 23, 2021, GE Healthcare announced the purchase of BK Medical, a company specializing in advanced surgical imaging for $1.45 billion. Read more here.

Purchase of late-stage cancer diagnostic tool developer Zionexa

In early May 2021, it became known that GE Healthcare bought the developer of tools for diagnosing late-stage cancer Zionexa. Cerianna (fluoroestradiol F-18), developed by the company, is used in PET imaging to detect ER-positive tumors and select treatment in patients with recurrent or metastatic breast cancer. Read more here.

2020

Purchase of Swedish CT technology developer Prismatic Sensors

In late November 2020, GE Healthcare acquired Swedish startup Prismatic Sensors, which developed deep silicon detector technology for photon counting computed tomography (PCCT). The financial terms of the deal were not disclosed. GE Healthcare expects to close the deal in January 2021. Read more here.

Sale of radiopharmacology business

In early September 2020 GE Healthcare , she sold her radio pharmacological business in a private USA network. Radioisotope Life Sciences (RLS) The buyer intends to invest $2 billion in business development.

The transaction and many years of negotiations were carried out by the international financial consulting company Captain. With this acquisition, Radioisotope Life Sciences will become the largest molecular imaging company in the United States. Terms of the deal were not disclosed. As part of the agreement, Radioisotope Life Sciences will continue to supply GE Healthcare's molecular imaging products, and Radioisotope Life Sciences will take advantage of a ten-year distribution partnership agreement.

GE Healthcare sold the radiopharmacology business to Radioisotope Life Sciences (RLS)

GE Healthcare's radiopharmacology business includes 31 offices in 18 states, including headquarters in Tampa, Florida. Now they will be headed by Radioisotope Life Sciences CEO Werner Gruner, Chief Investment Officer Jaco van Niekerk and Chief Operating Officer Shane Cobb. According to the company, Radioisotope Life Sciences plans to invest $2 billion over the next 10 years in expanding the network, as well as in scientific and technical research. The company also created a task force that will have to draw up an action plan in the face of an estimated increase in demand for specialized diagnostic services.

Nearly five hundred former GE Healthcare employees nationwide have joined the Radioisotope Life Sciences team. The company is expected to move its headquarters to Florida's east coast before the end of the year and begin talks with various economic development boards as well as municipalities over business expansion.^[1]

2019: Sale of GE Life Sciences biopharmaceutical unit for $21.4 billion

On February 25, 2019, General Electric announced the sale of the biopharmaceutical business (a unit of GE Life Sciences, part of GE Healthcare) to Danaher for $21.4 billion. Danaher says the deal will be fully completed by the fourth quarter of 2019. Read more here.

2018

Sale to Caradigm

On June 13, 2018, GE Healthcare announced the sale of public health software manufacturer Caradigm to Inspirata, an oncology software developer based in Redmond, Washington. Read more here.

IT-Business sale for $1.05 billion

In early April 2018, GE Healthcare announced the sale of its IT-Business to Veritas Capital. With this deal, one of the world's largest medical technology manufacturers is increasing its focus on smart patient diagnostic equipment and network devices. Read more here.

On October 9, 2018, Veritas Capital announced the renaming of the Value-Based Care Solutions Group unit purchased from GE Healthcare. It was named Virence Health Technologies. Read more here.

2017

Purchase of Puridify

On December 1, 2017, U.S. medical device manufacturer GE Healthcare announced the acquisition of Puridify Limited. The value of the transaction was not disclosed.

The FibroSelect nanofiber-based substance purification platform, thanks to GE Healthcare, is expected to improve performance during the process development phase and small-scale biopharmaceutical production. GE Healthcare is ready to invest even more in it to bring the platform to the mass market and fully integrate into the cleaning machines of the company itself. Read more here.

Purchase of Novia Strategies

In July 2017, GE Healthcare announced the acquisition of medical consulting providers Novia Strategies with the aim of expanding its American consulting business in the healthcare market. The value of the transaction is not disclosed, as well as the time frame during which all formalities regarding the contract are planned to be fulfilled. Purchase of Novia Strategies.

2010

€3 million investment in an Irish innovation centre

In April 2010, GE Healthcare announced an investment of €3 million in the Technology Research for Independent Living Centre (TRIL), an Irish center that reveals the possibilities of innovative technologies that allow older people to lead independent lifestyles.

MedPlexus takeover

On March 24, 2010, GE Healthcare announced its takeover of MedPlexus.

2008: Whatman takeover

On February 4, 2008, GE Healthcare announced it was closing a deal to buy Whatman, a global provider of filtering solutions. During the transaction, Whatman was valued at £363 million (or $713 million).